European society guidelines
180 current official clinical documents from European societies, in PDF. Sources: ESMO (88), ESC (34), EULAR (26), ERS (19), KDIGO (13). Main themes: oncology (71), chronic diseases (51) and cardiovascular (33).
Sign up for our AI library search toolSign up →Sections
Themes
180 documents
Prevention2
Infectious diseases2
HIV, hepatitis and STIs1
Cardiovascular33
Hypertension5
- 2024 ESC Guidelines for the management of elevated blood pressure and hypertensionEurope · ESC · 2024PDF ↗
- 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEurope · ESC · 2022PDF ↗
- 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEurope · ERS · 2022PDF ↗
- Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline eraEurope · ERS · 2021PDF ↗
- 2018 ESC/ESH Guidelines for the management of arterial hypertensionEurope · ESC · 2018PDF ↗
Cardiovascular risk and lipids9
- 2025 ESC Guidelines for the management of cardiovascular disease and pregnancyEurope · ESC · 2025PDF ↗
- 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetesEurope · ESC · 2023PDF ↗
- 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgeryEurope · ESC · 2022PDF ↗
- EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndromeEurope · EULAR · 2022PDF ↗
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practiceEurope · ESC · 2021PDF ↗
- 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular diseaseEurope · ESC · 2020PDF ↗
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDEurope · ESC · 2019PDF ↗
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskEurope · ESC · 2019PDF ↗
- 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyEurope · ESC · 2018PDF ↗
Heart disease19
- 2026 ESC Guidelines for the management of heart failureEurope · ESC · 2026PDF ↗
- 2026 ESC Guidelines on cardiac rehabilitationEurope · ESC · 2026PDF ↗
- 2025 ESC Guidelines for the management of myocarditis and pericarditisEurope · ESC · 2025PDF ↗
- 2025 ESC/EACTS Guidelines for the management of valvular heart diseaseEurope · ESC · 2025PDF ↗
- 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)Europe · ESC · 2024PDF ↗
- 2024 ESC Guidelines for the management of chronic coronary syndromesEurope · ESC · 2024PDF ↗
- 2023 ESC Guidelines for the management of acute coronary syndromesEurope · ESC · 2023PDF ↗
- 2023 ESC Guidelines for the management of cardiomyopathiesEurope · ESC · 2023PDF ↗
- 2023 ESC Guidelines for the management of endocarditisEurope · ESC · 2023PDF ↗
- 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac deathEurope · ESC · 2022PDF ↗
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEurope · ESC · 2021PDF ↗
- 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapyEurope · ESC · 2021PDF ↗
- 2021 ESC/EACTS Guidelines for the management of valvular heart diseaseEurope · ESC · 2021PDF ↗
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)Europe · ESC · 2020PDF ↗
- 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationEurope · ESC · 2020PDF ↗
- 2020 ESC Guidelines for the management of adult congenital heart diseaseEurope · ESC · 2020PDF ↗
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromesEurope · ESC · 2019PDF ↗
- 2018 ESC Guidelines for the diagnosis and management of syncopeEurope · ESC · 2018PDF ↗
- 2018 ESC/EACTS Guidelines on myocardial revascularizationEurope · ESC · 2018PDF ↗
Chronic diseases51
Diabetes2
Respiratory disease16
- ERS/ESGE/ESTS clinical practice guidelines on endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancerEurope · ERS · 2026PDF ↗
- ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease: a multidisciplinary, evidence-based approach to best managementEurope · ERS · 2026PDF ↗
- Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2025PDF ↗
- ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseEurope · ERS · 2025PDF ↗
- ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft- versus -host disease in adultsEurope · ERS · 2024PDF ↗
- “International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, et al. Eur Respir J 2014; 43: 343–373.Europe · ERS · 2022PDF ↗
- 2022 ERS guidelines for asthma diagnosis in adultsEurope · ERS · 2022PDF ↗
- Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapyEurope · ESMO · 2021PDF ↗
- ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failureEurope · ERS · 2021PDF ↗
- Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆Europe · ESMO · 2021PDF ↗
- Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆Europe · ESMO · 2021PDF ↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOSEurope · ESMO · 2020PDF ↗
- Recent eUpdate to the ESMO Clinical Practice Guidelines on early and locally advanced non-small-cell lung cancer (NSCLC)Europe · ESMO · 2020PDF ↗
- Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guidelineEurope · ERS · 2020PDF ↗
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)Europe · ESC · 2019PDF ↗
- “International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague.Eur Respir J2014; 43: 343–373.Europe · ERS · 2018PDF ↗
Kidney disease14
- 2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA)Europe · ESC · 2026PDF ↗
- EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 updateEurope · EULAR · 2026PDF ↗
- KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)Europe · KDIGO · 2026PDF ↗
- KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)Europe · KDIGO · 2025PDF ↗
- KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summaryEurope · KDIGO · 2025PDF ↗
- KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)Europe · KDIGO · 2025PDF ↗
- KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in ChildrenEurope · KDIGO · 2025PDF ↗
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseEurope · KDIGO · 2024PDF ↗
- KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITISEurope · KDIGO · 2024PDF ↗
- Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2024PDF ↗
- ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinomaEurope · ESMO · 2021PDF ↗
- KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney DiseaseEurope · KDIGO · 2021PDF ↗
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular DiseasesEurope · KDIGO · 2021PDF ↗
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2019PDF ↗
Bone, joint and rheumatology18
- EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis: 2025 updateEurope · EULAR · 2026PDF ↗
- EULAR recommendations for the management of Behçet’s syndrome: 2025 updateEurope · EULAR · 2026PDF ↗
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 updateEurope · EULAR · 2026PDF ↗
- EULAR recommendations for a core dataset to support clinical care and translational and observational research in systemic lupus erythematosusEurope · EULAR · 2025PDF ↗
- EULAR recommendations for the treatment of systemic sclerosis: 2023 updateEurope · EULAR · 2025PDF ↗
- EULAR recommendations for the management of ANCA-associated vasculitis: 2022 updateEurope · EULAR · 2024PDF ↗
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateEurope · EULAR · 2024PDF ↗
- EULAR recommendations for the management of systemic lupus erythematosus: 2023 updateEurope · EULAR · 2024PDF ↗
- EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 updateEurope · EULAR · 2024PDF ↗
- EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosisEurope · EULAR · 2024PDF ↗
- EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 updateEurope · EULAR · 2024PDF ↗
- KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisEurope · KDIGO · 2024PDF ↗
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateEurope · EULAR · 2023PDF ↗
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 updateEurope · EULAR · 2020PDF ↗
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateEurope · EULAR · 2020PDF ↗
- EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapiesEurope · EULAR · 2020PDF ↗
- EULAR recommendations for the health professional's approach to pain management in inflammatory arthritis and osteoarthritisEurope · EULAR · 2018PDF ↗
- EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practiceEurope · EULAR · 2018PDF ↗
Oncology71
- Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2026PDF ↗
- ESMO Clinical Practice Guideline Express Update on daraxonrasib in the treatment of metastatic pancreatic cancerEurope · ESMO · 2026PDF ↗
- Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2026PDF ↗
- Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2026PDF ↗
- Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2026PDF ↗
- 2303P Barriers related to adherence and implementation of the ESMO clinical practice guidelines: A survey provided by the ESMO community oncologists task forceEurope · ESMO · 2025PDF ↗
- Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2025PDF ↗
- Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2025PDF ↗
- Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2025PDF ↗
- Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2025PDF ↗
- Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2024PDF ↗
- ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinomaEurope · ESMO · 2024PDF ↗
- ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemiaEurope · ESMO · 2024PDF ↗
- ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemiaEurope · ESMO · 2024PDF ↗
- Human immunodeficiency virus-associated lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2024PDF ↗
- Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2024PDF ↗
- Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to ‘Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up’)Europe · ESMO · 2023PDF ↗
- Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agentsEurope · ESMO · 2023PDF ↗
- Venous thromboembolism in cancer patients: ESMO Clinical Practice GuidelineEurope · ESMO · 2023PDF ↗
- 1586P Improving the management of anaemia in cancer patients receiving chemotherapy: ESMO clinical practice guidelines in actionEurope · ESMO · 2022PDF ↗
- Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2022PDF ↗
- Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2022PDF ↗
- Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2022PDF ↗
- ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancerEurope · ESMO · 2022PDF ↗
- Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2022PDF ↗
- Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2022PDF ↗
- The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice GuidelineEurope · ESMO · 2022PDF ↗
- Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆Europe · ESMO · 2021PDF ↗
- Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2021PDF ↗
- EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumoursEurope · ESMO · 2021PDF ↗
- ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerEurope · ESMO · 2021PDF ↗
- Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†Europe · ESMO · 2021PDF ↗
- Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2021PDF ↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancerEurope · ESMO · 2021PDF ↗
- Recent eUpdate to the ESMO Clinical Practice Guidelines on renal cell carcinoma on cabozantinib and nivolumab for first-line clear cell renal cancerEurope · ESMO · 2021PDF ↗
- Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice GuidelinesEurope · ESMO · 2021PDF ↗
- Updated treatment recommendations for newly diagnosed epithelial ovarian carcinoma from the ESMO Clinical Practice GuidelinesEurope · ESMO · 2021PDF ↗
- Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2020PDF ↗
- Bone health in cancer: ESMO Clinical Practice GuidelinesEurope · ESMO · 2020PDF ↗
- Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatmentEurope · ESMO · 2020PDF ↗
- Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†Europe · ESMO · 2020PDF ↗
- Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2020PDF ↗
- Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2020PDF ↗
- Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2020PDF ↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOSEurope · ESMO · 2020PDF ↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSOEurope · ESMO · 2020PDF ↗
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2020PDF ↗
- Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2019PDF ↗
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2019PDF ↗
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2019PDF ↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOSEurope · ESMO · 2019PDF ↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOSEurope · ESMO · 2019PDF ↗
- Recent eUpdates to the ESMO Clinical Practice Guidelines on hepatocellular carcinoma, cancer of the pancreas, soft tissue and visceral sarcomas, cancer of the prostate and gastric cancerEurope · ESMO · 2019PDF ↗
- Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2019PDF ↗
- Delirium in adult cancer patients: ESMO Clinical Practice GuidelinesEurope · ESMO · 2018PDF ↗
- Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice GuidelinesEurope · ESMO · 2018PDF ↗
- Diarrhoea in adult cancer patients: ESMO Clinical Practice GuidelinesEurope · ESMO · 2018PDF ↗
- Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2018PDF ↗
- Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2018PDF ↗
- Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesEurope · ESMO · 2018PDF ↗
- Management of cancer pain in adult patients: ESMO Clinical Practice GuidelinesEurope · ESMO · 2018PDF ↗
- Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2018PDF ↗
- Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2018PDF ↗
- Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2018PDF ↗
Maternal health2
Mental health and neurology1
Other18
- 2024 ESC Guidelines for the management of peripheral arterial and aortic diseasesEurope · ESC · 2024PDF ↗
- EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 updateEurope · EULAR · 2024PDF ↗
- Joint ERS/EACTS/ESTS clinical practice guidelines on adults with spontaneous pneumothoraxEurope · ERS · 2024PDF ↗
- Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆Europe · ESMO · 2022PDF ↗
- Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2022PDF ↗
- ERS clinical practice guidelines on treatment of sarcoidosisEurope · ERS · 2021PDF ↗
- EULAR recommendations for intra-articular therapiesEurope · EULAR · 2021PDF ↗
- EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs)Europe · EULAR · 2021PDF ↗
- Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆Europe · ESMO · 2021PDF ↗
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆Europe · ESMO · 2021PDF ↗
- Real-life evidence in ERS clinical practice guidelines: from foes to friendsEurope · ERS · 2021PDF ↗
- “ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.” Alyn H. Morice, Eva Millqvist, Kristina Bieksiene, Surinder S. Birring, Peter Dicpinigaitis, Christian Domingo Ribas, Michele Hilton Boon, Ahmad Kantar, Kefang Lai, Lorcan McGarvey, David Rigau, Imran Satia, Jacky Smith, Woo-Jung Song, Thomy Tonia, Jan W.K. van den Berg, Mirjam J.G. van Manen and Angela Zacharasiewicz. Eur Respir J 2020; 55: 1901136.Europe · ERS · 2020PDF ↗
- ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesotheliomaEurope · ERS · 2020PDF ↗
- 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaEurope · ESC · 2019PDF ↗
- ERS and ATS diagnostic guidelines for primary ciliary dyskinesia: similarities and differences in approach to diagnosisEurope · ERS · 2019PDF ↗
- ERS guidelines on the diagnosis and treatment of chronic cough in adults and childrenEurope · ERS · 2019PDF ↗
- EULAR recommendations for the management of antiphospholipid syndrome in adultsEurope · EULAR · 2019PDF ↗
- Waldenström’s macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2018PDF ↗